Dianomi Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

Dianomi Therapeutics General Information

Description

Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis. The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, enabling patients to have improved, sustained-release delivery of active biologics.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 504 South Rosa Road
  • Suite 200
  • Madison, WI 53719
  • United States
+1 (303) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dianomi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 21-Aug-2022 000.00 Completed Out of Business
4. Early Stage VC (Series A) 09-Feb-2021 000 000.00 0000 Completed Pre-Clinical Trials
3. Angel (individual) 00000 00.00 Completed Pre-Clinical Trials
2. Early Stage VC 04-Feb-2019 $3M $3.19M Completed Pre-Clinical Trials
1. Angel (individual) 25-Jan-2019 $185K $185K Completed Pre-Clinical Trials
To view Dianomi Therapeutics’s complete valuation and funding history, request access »

Dianomi Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially
Biotechnology
Madison, WI
7 As of 2022
000.00
00000000 00 000.00

000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Suzhou, China
00.000
00.00 0000-00-00
00000000000 00.000

000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
0000000000000
Redwood City, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dianomi Therapeutics Competitors (145)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AbogenBio Venture Capital-Backed Suzhou, China 00.000 00000000000 00.000
Adverum Biotechnologies Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
Nanna Therapeutics Formerly VC-backed Cambridge, United Kingdom 00 00000 000000&0 00000
Scorpion Therapeutics Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
You’re viewing 5 of 145 competitors. Get the full list »

Dianomi Therapeutics Patents

Dianomi Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190358344-A1 Mineral coated microparticles for sustained delivery of steroids Inactive 23-May-2018 00000000000

Dianomi Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dianomi Therapeutics FAQs

  • When was Dianomi Therapeutics founded?

    Dianomi Therapeutics was founded in 2017.

  • Who is the founder of Dianomi Therapeutics?

    Anna Clements Ph.D, Kurtis Knapp Ph.D, Barry Kurokawa, Martin Ostrowski JD, William Murphy Ph.D, and Carter Cliff Ph.D are the founders of Dianomi Therapeutics.

  • Where is Dianomi Therapeutics headquartered?

    Dianomi Therapeutics is headquartered in Madison, WI.

  • What is the size of Dianomi Therapeutics?

    Dianomi Therapeutics has 7 total employees.

  • What industry is Dianomi Therapeutics in?

    Dianomi Therapeutics’s primary industry is Biotechnology.

  • Is Dianomi Therapeutics a private or public company?

    Dianomi Therapeutics is a Private company.

  • What is Dianomi Therapeutics’s current revenue?

    The current revenue for Dianomi Therapeutics is 000000.

  • How much funding has Dianomi Therapeutics raised over time?

    Dianomi Therapeutics has raised $10.8M.

  • Who are Dianomi Therapeutics’s competitors?

    AbogenBio, Adverum Biotechnologies, CytomX Therapeutics, Nanna Therapeutics, and Scorpion Therapeutics are some of the 145 competitors of Dianomi Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »